Clover Health Files 8-K

Ticker: CLOV · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1801170

Clover Health Investments, Corp. /De 8-K Filing Summary
FieldDetail
CompanyClover Health Investments, Corp. /De (CLOV)
Form Type8-K
Filed DateJan 13, 2025
Risk Levellow
Pages4
Reading Time5 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: reporting, regulation-fd

Related Tickers: CLOV

TL;DR

CLOV filed a routine 8-K, no major news.

AI Summary

Clover Health Investments, Corp. filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.

Why It Matters

This filing indicates routine corporate reporting and does not appear to contain new material information that would immediately impact investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for reporting purposes and does not disclose any new material risks or events.

Key Players & Entities

  • CLOVER HEALTH INVESTMENTS, CORP. (company) — Registrant
  • 0001801170 (company) — Central Index Key
  • 001-39252 (company) — SEC File Number
  • January 13, 2025 (date) — Date of Report

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant is CLOVER HEALTH INVESTMENTS, CORP.

In which state was Clover Health Investments, Corp. incorporated?

Clover Health Investments, Corp. was incorporated in Delaware.

What is the Commission File Number for Clover Health Investments, Corp.?

The Commission File Number for Clover Health Investments, Corp. is 001-39252.

What is the IRS Employer Identification Number for Clover Health Investments, Corp.?

The IRS Employer Identification Number for Clover Health Investments, Corp. is 98-1515192.

Filing Stats: 1,325 words · 5 min read · ~4 pages · Grade level 15.3 · Accepted 2025-01-13 09:02:59

Key Financial Figures

  • $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On December 17, 2024, Clover Health Investments, Corp. (the "Company") issued a press release announcing that its Chief Executive Officer, Andrew Toy, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2024, at 4:30 p.m. Eastern Time. A live webcast of the presentation will be accessible through the investor relations section of the Company's website. The slide presentation to be used during the presentation is attached hereto as Exhibit 99.2 and incorporated herein by reference. On January 13, 2025, the Company issued a press release announcing preliminary Medicare Advantage Annual Election Period ("AEP") results, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information set forth in this Item 7.01 (including Exhibit 99.1 and Exhibit 99.2) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements regarding future events and Clover Health's future results of operations, financial condition, market size and opportunity, business strategy and plans, and the factors affecting our performance and our objectives for future operations. Forward-looking statements are not guarantees of future performance and you are cautioned not to place undue reliance on such statements. In some cases, you can identify forward looking statements because they contain words such as "may," "will," "should,"

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press release dated January 13, 2025 99.2 Slide Presentation dated January 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Clover Health Investments, Corp. Date: January 13, 2025 By: /s/ Peter Kuipers Name: Peter Kuipers Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.